The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two ...

A multi‐centre Ghanaian study found that the prevalence of CKD in people with hypertension and/or diabetes was rising; the ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced updated data for povetacicept (pove) in IgA nephropathy ...

A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.

Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction ...

United States real-world studies highlight the importance of controlling lupus nephritis to improve patient prognosis.

The urinary albumin-creatinine ratio (UACR) is more strongly associated with kidney failure than the urinary ...

Bayer announced today that data from across the KERENDIA (R) (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) ...